Oct 20 (Reuters) – Verrica Pharmaceuticals Inc: * VERRICA PHARMACEUTICALS RECEIVES POSITIVE FEEDBACK FROM THE EUROPEAN MEDICINES AGENCY (EMA) SUPPORTING A CLEAR REGULATORY PATH FORWARD TO FILE FOR APPROVAL OF YCANTH® IN THE EUROPEAN UNION * VERRICA PHARMACEUTICALS INC – PLANS REGULATORY SUBMISSION FOR YCANTH BY Q4 2026 Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Adds USTR statement on China, paragraphs 1 and 8-10) * Taiwan could figure in to…
(Adds details) Oct 20 (Reuters) - Israeli club Maccabi Tel Aviv will not accept any…
By Helen Coster NEW YORK, Oct 20 (Reuters) - The University of Arizona on Monday…
Oct 21 (Reuters) - Alicanto Minerals Ltd: * TRADING HALT * SEEKS TRADING HALT REQUESTED…
Oct 20 (Reuters) - Petroleo Brasileiro SA Petrobras : * SAYS IT SIGNED WITH PPSA…
By Greg Bensinger, Shubham Kalia and Deborah Mary Sophia SAN FRANCISCO (Reuters) -Amazon.com said on…